NKTR News

Class Action Initiated by Pomerantz LLP Against Nektar Therapeutics – NKTR

ODD CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Oddity Tech (ODD) Investors of Securities Class Action Deadline on May 11, 2026 Ready to Announce with Confidence?

NKTR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 Ready to Announce with Confidence?

NKTR DEADLINE NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - NKTR

Class Action Filing Announced by Pomerantz LLP Concerning Nektar Therapeutics – NKTR

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm

NKTR UPCOMING DEADLINE : The Gross Law Firm Alerts Nektar Therapeutics Stockholders of Securities Class Action - Contact the Firm

Class Action Filing Pursued by Pomerantz LLP Concerning Nektar Therapeutics – NKTR